1. Home
  2. BHR vs ANTX Comparison

BHR vs ANTX Comparison

Compare BHR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHR

Braemar Hotels & Resorts Inc.

N/A

Current Price

$2.29

Market Cap

159.3M

Sector

Real Estate

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

N/A

Current Price

$4.95

Market Cap

172.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHR
ANTX
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
172.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BHR
ANTX
Price
$2.29
$4.95
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
662.9K
196.7K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
8.47%
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.88
$1.00
52 Week High
$3.19
$6.91

Technical Indicators

Market Signals
Indicator
BHR
ANTX
Relative Strength Index (RSI) 61.20 56.37
Support Level $2.19 $3.91
Resistance Level $2.61 $5.15
Average True Range (ATR) 0.09 0.32
MACD 0.04 0.02
Stochastic Oscillator 97.14 66.67

Price Performance

Historical Comparison
BHR
ANTX

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: